Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Institutional Investor > Versant Venture Management, Llc > Profile

Instuitional Investor - Versant Venture Management, Llc

Fund Profile
Filing Period:
Fund Name: Versant Venture Management, Llc
Portfolio Value $60,208,868
Top 13F Holdings
Filing Period:
No. Security Ticker Shares Value % Port
1.
Monte Rosa Therapeutics Inc.
 GLUE 5,652,922 $26,229,558 43.56%
2.
Crispr Therapeutics Ag
 CRSP 498,558 $16,965,929 28.18%
3.
Contineum Therapeutics Inc.
 918,163 $6,408,778 10.64%
4.
Skye Bioscience Inc.
 2,007,704 $3,192,249 5.3%
5.
Repare Therapeutics Inc.
 RPTX 2,646,657 $2,609,339 4.33%
Insider Monkey Quarterly Strategy
+373.4% Insider Monkey Quarterly Strategy
+154.9% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
300%
200%
100%
Subscribe Now

Returns since its inception in May 2014 (through February 19th, 2025)